Major Contributions of Eric Lefkofsky in Cancer Treatment
Cancer is the single name representing more than hundreds of diseases. Despite the fact that cancer has endlessly been consuming and depriving health resources, it’s actually due to the ability of the cancerous cells to abnormally increase and develop uncontrollably. In the course harming sound cells along the way. Stunned by its complexity, the fight to combat cancer have been fruitless until now. However, gratitude’s to technology, a journey in fighting cancer have been revolutionized. Currently, Eric Lefkofskys, a co-founder of Tempus, is at the forefront leading the fight against cancer.
Eric Lefkofsky studied and graduated with Ann Arbor from the University of Michigan. His thirst for education sends him back, two years down the line, to the University of Michigan Law School. However, he have never specialized in anything related to his studies as he believed in transforming the world rather than following his career.
Eric started the fight against cancer when his wife acquired breast cancer. His interest in care and treatment of cancer patients after that began to grow. In the course, Eric discovered a lot of mischiefs in data collection, despite the use of Electronic Health Records. His determination and self-drive towards the care and treatment of cancer patient stirred co-founding of Tempus.
Tempus is a firm targeting to improve the health care of cancer patients. Tempus firm has overcome several challenges in the treatment and care of cancer patients using the new technology. To start with, Tempus has come up with an efficient way of gathering and examining molecular and clinical data. Through this work fostered by Eric and Tempus, clinical and molecular data collected through the process of gene sequencing can be matched. Thus, providing a broad scheme in battling cancer, which for a long time has been a significant problem in the healthcare system.
Secondly, Tempus has also device software that collects and store information in a structured way that can easily be recognized and examined through optical features. Before, the data for cancer patients were recorded manually, which were challenging to trace rendering difficulties in the treatment of cancer. Through this technology, in the coming future, Eric and his colleagues ascertain that doctors will be confident in prescribing a specific drug for treatment of certain types of cancer, as a result of availability and easy access of patient’s information.
To conclude, Tempus firm uses new technological methods to gather and investigate a lot of genomic information. By utilizing measurable examination and exclusive designs, they reveal chances to help a patient’s doctor in giving more exact and customized pharmaceutical care.